Gilead Sciences Announces Second Quarter 2021 Financial Results

Go back to Gilead Sciences Announces Second Quarter 2021 Financial Results

Gilead Sciences (GILD) Tops Q2 EPS by 14c

July 29, 2021 4:05 PM EDT

Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $1.87, $0.14 better than the analyst estimate of $1.73. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.07 billion.

GUIDANCE:

Gilead Sciences sees FY2021 EPS of $6.90-$7.25, versus the consensus of... More